Skip to main content
. Author manuscript; available in PMC: 2020 Apr 23.
Published in final edited form as: Neurodegener Dis. 2019 Apr 23;19(1):4–11. doi: 10.1159/000499113

Table 2.

Association between Decision-Maker Type and Agreement with the Use of Assisted Dying in Advanced Dementiaa

Characteristic Total No. (%)
of Decision-
Makers with
Characteristic
(N=218)
No. (%) of Decision-Makers
Agreeing with Assisted Dying
(N=92)
Odds Ratiob for Agreement with Assisted Dying (95% Confidence Interval)
Characteristic
Present
Characteristic
Absent
Unadjusted Adjusted
Surrogates (versus physicians) 156 (71.6) 79 (36.2) 13 (6.0) 3.87 (1.94, 7.69)e 3.87 (1.94, 7.69)
Covariates
Age > 55 (median)c 106 (48.8) 54 (24.9) 38 (17.5) 1.99 (1.15, 3.45)e
Femalec 133 (61.3) 62 (28.6) 30 (13.8) 1.57 (0.90, 2.76)
No religion (versus any)c 45 (21.4) 24 (11.4) 67 (31.9) 1.67 (0.86, 3.24)
Any prior major treatment decision in dementiac,d 97 (44.9) 29 (13.4) 61 (28.2) 0.41 (0.23, 0.71)e
a

Decision-makers were 42.2% (N=92/218) agreeing with the use of assisted dying in advanced dementia.

b

Logistic regression was used in all analyses, and unadjusted and adjusted odds ratio were computed.

c

The total number of missing values was: age, N=1; female, N=1; no religion, N=8 (missing values, N=3; refused, N=5); and any prior major treatment decision, N=2.

d

Decision-makers reported whether they had or had not previously made any major decision about the use of antibiotics and/or artificial hydration for a person with advanced dementia.

e

Variables that were significant at P < 0.10 in bivariable analyses and entered into the multivariable model.